Suchergebnisse - "Tolosa-Vilella, Carles"

PubPharm (49)

1

Nailfold videocapillaroscopy patterns in systemic sclerosis : implications for cutaneous subsets, disease features and prognostic value for survival

enthalten in: Clinical and experimental rheumatology | 2023

von Tolosa-Vilella, C. | Del Mar Rodero-Roldán, M. | Guillen-Del-Castillo, A. | +25

2

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis : Data from the Spanish Scleroderma Registry (RESCLE)

enthalten in: Autoimmunity reviews | 2022

von Carbonell, C. | Marcos, M. | Guillén-Del-Castillo, A. | +32

CommentIn: Autoimmun Rev. 2022 Nov;21(11):103181. - PMID 35987484

3

Left ventricular diastolic dysfunction in systemic sclerosis : Clinical, immunological and survival differences in the Spanish RESCLE registry

enthalten in: Seminars in arthritis and rheumatism | 2022

von González García, A. | Fabregate, M. | Manzano, L. | +25

4

Author Correction : Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

enthalten in: Scientific reports | 2022

von Guillén-Del-Castillo, A. | Meseguer, M. | Fonollosa-Pla, V. | +89

ErratumFor: Sci Rep. 2022 Mar 28;12(1):5289. - PMID 35347225

5

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

enthalten in: Scientific reports | 2022

von Guillén-Del-Castillo, A. | Meseguer, M. | Fonollosa-Pla, V. | +89

ErratumIn: Sci Rep. 2022 Jul 28;12(1):12947. - PMID 35902683

6

Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis : Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2022

von Iniesta Arandia, N. | Espinosa, G. | Guillén Del Castillo, A. | +14

7

Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort : Derivation and internal validation' [AUTREV 19-5 (2020) 102507

enthalten in: Autoimmunity reviews | 2021

von Rubio-Rivas, M. | Corbella, X. | Guillén-Del-Castillo, A. | +30

ErratumFor: Autoimmun Rev. 2020 May;19(5):102507. - PMID 32194200

8

The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)

enthalten in: Rheumatology (Oxford, England) | 2021

von Pestaña-Fernández, M. | Rubio-Rivas, M. | Tolosa-Vilella, C. | +21

9

Serodiscordant patients with systemic sclerosis : when antibody does not correspond to skin involvement

enthalten in: Clinical and experimental rheumatology | 2020

von Iniesta Arandia, N. | Espinosa, G. | Tolosa Vilella, C. | +23

10

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort : Derivation and internal validation

enthalten in: Autoimmunity reviews | 2020

von Rubio-Rivas, M. | Corbella, X. | Guillén-Del-Castillo, A. | +29

ErratumIn: Autoimmun Rev. 2021 May;20(5):102793. - PMID 33766615

1
2
3
4
5
Nächster »
[5]